These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 10933882

  • 1. Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice.
    Fosgerau K, Westergaard N, Quistorff B, Grunnet N, Kristiansen M, Lundgren K.
    Arch Biochem Biophys; 2000 Aug 15; 380(2):274-84. PubMed ID: 10933882
    [Abstract] [Full Text] [Related]

  • 2. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
    Andersen B, Westergaard N.
    Biochem J; 2002 Oct 15; 367(Pt 2):443-50. PubMed ID: 12099891
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.
    Andersen B, Rassov A, Westergaard N, Lundgren K.
    Biochem J; 1999 Sep 15; 342 Pt 3(Pt 3):545-50. PubMed ID: 10477265
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
    Mackay P, Ynddal L, Andersen JV, McCormack JG.
    Diabetes Obes Metab; 2003 Nov 15; 5(6):397-407. PubMed ID: 14617225
    [Abstract] [Full Text] [Related]

  • 5. Characterization of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) as an inhibitor of brain glycogen shunt activity.
    Walls AB, Sickmann HM, Brown A, Bouman SD, Ransom B, Schousboe A, Waagepetersen HS.
    J Neurochem; 2008 May 15; 105(4):1462-70. PubMed ID: 18221367
    [Abstract] [Full Text] [Related]

  • 6. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z, Németi B.
    Toxicol Sci; 2007 Nov 15; 100(1):44-53. PubMed ID: 17693424
    [Abstract] [Full Text] [Related]

  • 7. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
    Latsis T, Andersen B, Agius L.
    Biochem J; 2002 Nov 15; 368(Pt 1):309-16. PubMed ID: 12186629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glycogen is a preferred glutamate precursor during learning in 1-day-old chick: biochemical and behavioral evidence.
    Gibbs ME, Lloyd HG, Santa T, Hertz L.
    J Neurosci Res; 2007 Nov 15; 85(15):3326-33. PubMed ID: 17455305
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucagon challenge in the rat: a robust method for the in vivo assessment of Glycogen phosphorlyase inhibitor efficacy.
    Loxham SJ, Teague J, Poucher SM, De Schoolmeester J, Turnbull AV, Carey F.
    J Pharmacol Toxicol Methods; 2007 Nov 15; 55(1):71-7. PubMed ID: 16713718
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of glycogen phosphorylase stimulates ventromedial hypothalamic nucleus AMP-activated protein kinase: Activity and neuronal nitric oxide synthase protein expression in male rats.
    Alhamami HN, Alshamrani A, Briski KP.
    Physiol Rep; 2017 Dec 15; 5(23):. PubMed ID: 29199177
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens.
    Gibbs ME, Anderson DG, Hertz L.
    Glia; 2006 Aug 15; 54(3):214-22. PubMed ID: 16819764
    [Abstract] [Full Text] [Related]

  • 18. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.
    Martin WH, Hoover DJ, Armento SJ, Stock IA, McPherson RK, Danley DE, Stevenson RW, Barrett EJ, Treadway JL.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1776-81. PubMed ID: 9465093
    [Abstract] [Full Text] [Related]

  • 19. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Kaiser A, Nishi K, Gorin FA, Walsh DA, Bradbury EM, Schnier JB.
    Arch Biochem Biophys; 2001 Feb 15; 386(2):179-87. PubMed ID: 11368340
    [Abstract] [Full Text] [Related]

  • 20. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models.
    Furukawa S, Murakami K, Nishikawa M, Nakayama O, Hino M.
    J Antibiot (Tokyo); 2005 Aug 15; 58(8):503-6. PubMed ID: 16266121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.